Abeona Therapeutics Inc vs WD 40 Company — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while WD 40 Company trades at $233.59 (market cap $3.13B). The key difference: WD 40 Company is far larger — about 7.4× Abeona Therapeutics Inc's market cap, and WD 40 Company pays a 1.75% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | WDFC | |
|---|---|---|
Market Cap | $421.19M | $3.13B |
Sector | Health | Technology |
52-Week High | $7.45 | $264.91 |
52-Week Low | $4.17 | $187.52 |
Enterprise Value | $276.10M | $3.18B |
Dividend Yield | — | 1.75% |
Trailing returns across standard periods
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →WD-40 Company is a global marketing organization dedicated to creating 'positive lasting memories' by developing and selling products that solve maintenance and cleaning problems. Built around the legendary WD-40 Multi-Use Product, the company operates an asset-light business model, focusing on brand management and innovation while utilizing a network of contract manufacturers to deliver solutions across the Americas, EIMEA, and Asia-Pacific.
Read more on WDFC →